Monica Fadanelli

Monica Fadanelli

Auto-generated profile, based on publicly available information

Monica Fadanelli

Emory University Rollins School of Public Health, Atlanta, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2020 in International Journal of Drug Policy
Verified
Journal Article
Closed access
HCHannah Lf Cooper
Hannah Lf Cooper
DCDavid H. Cloud
David H. Cloud
PFPatricia R. Freeman
Patricia R. Freeman
MFMonica Fadanelli
Monica Fadanelli
TGTravis Green
Travis Green
AYApril M. Young
April M. Young

18 November 2019 in International Journal of Drug Policy
Verified
Journal Article
Closed access
MFMonica Fadanelli
Monica Fadanelli
DCDavid H. Cloud
David H. Cloud
UIUmedjon Ibragimov
Umedjon Ibragimov
ABApril M. Ballard
April M. Ballard
NPNadya Prood
Nadya Prood
HCHannah L.F. Cooper
Hannah L.F. Cooper

8 January 2022 in Harm Reduction Journal
Verified
Journal Article
Open access
PDF file
MFMonica Fadanelli
Monica Fadanelli
HCHannah L. F. Cooper
Hannah L. F. Cooper
PFPatricia R. Freeman
Patricia R. Freeman
ABApril M. Ballard
April M. Ballard
UIUmed Ibragimov
Umed Ibragimov
AYApril M. Young
April M. Young
Background: Expanding access to sterile syringes in rural areas is vital, as injection-related epidemics expand beyond metropolitan areas globally. While pharmacies have potential to be an easily accessible source of sterile syringes, research in cities has identified moral, legal and ethical barriers that preclude over-the-counter (OTC) sales to people who inject drugs (PWID). The current study builds on prior urban-based research by elucidating (1) pharmacy OTC policies and (2) pharmacists’ rationale for, and barriers and facilitators to, OTC syringe sales in a US rural area hard hit by drug-related epidemics. Methods: We conducted 14 semi-structured interviews with pharmacists recruited from two Eastern Kentucky health districts. Interview domains included experiences with, and attitudes toward, selling OTC syringes to PWID. Constructivist grounded theory methods were used to analyze verbatim transcripts. Results: Most pharmacists operated “restrictive OTC” pharmacies (n = 8), where patients were required to have a prescription or proof of medical need to purchase a syringe. The remainder (n = 6) operated “open OTC” pharmacies, which allowed OTC syringe sales to most patients. Both groups believed their pharmacy policies protected their community and pharmacy from further drug-related harm, but diverging policies emerged because of stigma toward PWID, perceptions of Kentucky law, and belief OTC syringe sales were harmful rather than protective to the community. Conclusion: Our results suggest that restrictive OTC pharmacy policies are rooted in stigmatizing views of PWID. Anti-stigma education about substance use disorder (SUD), human immunodeficiency virus (HIV), and Hepatitis C (HCV) is likely needed to truly shift restrictive pharmacy policy.